SpectrumDNA Graham Net Net from 2010 to 2026
| SPXA Stock | USD 0.01 0.00 0.000001% |
Graham Net Net | First Reported 2010-12-31 | Previous Quarter 0.001092 | Current Value 0.001037 | Quarterly Volatility 0.00885832 |
Check SpectrumDNA financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among SpectrumDNA's main balance sheet or income statement drivers, such as Interest Expense of 0.0, Selling General Administrative of 2.3 M or Total Revenue of 113.5 K, as well as many indicators such as Price To Sales Ratio of 6.0E-4, Dividend Yield of 0.0 or PTB Ratio of 1.0E-4. SpectrumDNA financial statements analysis is a perfect complement when working with SpectrumDNA Valuation or Volatility modules.
SpectrumDNA | Graham Net Net | Build AI portfolio with SpectrumDNA Stock |
Analyzing SpectrumDNA's Graham Net Net over time reveals critical patterns in financial health and operational efficiency. This metric helps investors evaluate trends, identify inflection points, and make informed decisions based on historical performance. Understanding how Graham Net Net has evolved provides context for assessing SpectrumDNA's current valuation and future prospects.
Latest SpectrumDNA's Graham Net Net Growth Pattern
Below is the plot of the Graham Net Net of SpectrumDNA over the last few years. It is SpectrumDNA's Graham Net Net historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in SpectrumDNA's overall financial position and show how it may be relating to other accounts over time.
| Graham Net Net | 10 Years Trend |
|
Graham Net Net |
| Timeline |
SpectrumDNA Graham Net Net Regression Statistics
| Arithmetic Mean | 0 | |
| Geometric Mean | 0 | |
| Coefficient Of Variation | 284.61 | |
| Mean Deviation | 0 | |
| Median | 0.0009 | |
| Standard Deviation | 0.01 | |
| Sample Variance | 0.000078 | |
| Range | 0.0365 | |
| R-Value | (0.41) | |
| Mean Square Error | 0.00007 | |
| R-Squared | 0.16 | |
| Significance | 0.11 | |
| Slope | (0.0007) | |
| Total Sum of Squares | 0 |
SpectrumDNA Graham Net Net History
About SpectrumDNA Financial Statements
SpectrumDNA stakeholders use historical fundamental indicators, such as SpectrumDNA's Graham Net Net, to determine how well the company is positioned to perform in the future. Although SpectrumDNA investors may analyze each financial statement separately, they are all interrelated. For example, changes in SpectrumDNA's assets and liabilities are reflected in the revenues and expenses on SpectrumDNA's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in SpectrumDNA. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether SpectrumDNA offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of SpectrumDNA's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Spectrumdna Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Spectrumdna Stock:Check out the analysis of SpectrumDNA Correlation against competitors. For information on how to trade SpectrumDNA Stock refer to our How to Trade SpectrumDNA Stock guide.You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Is Software - Application space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of SpectrumDNA. If investors know SpectrumDNA will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive SpectrumDNA assessment requires weighing all these inputs, though not all factors influence outcomes equally.
The market value of SpectrumDNA is measured differently than its book value, which is the value of SpectrumDNA that is recorded on the company's balance sheet. Investors also form their own opinion of SpectrumDNA's value that differs from its market value or its book value, called intrinsic value, which is SpectrumDNA's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because SpectrumDNA's market value can be influenced by many factors that don't directly affect SpectrumDNA's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between SpectrumDNA's value and its price as these two are different measures arrived at by different means. Investors typically determine if SpectrumDNA is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Meanwhile, SpectrumDNA's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.